NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 0.8600
-0.0100 (-1.15%)
Aug 3, 2026, 3:01 PM CET
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €11.02 million as of August 3, 2026. Its market cap has decreased by -32.14% in one year.
Market Cap
11.02M
Enterprise Value
9.41M
Revenue
188.00
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.86
ChartMarket Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 11.02M, a decrease of -43.38%. That is a compound annual growth rate of -10.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 11.02M | -26.15% |
| Dec 31, 2025 | 14.93M | -21.92% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
| Jul 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 34.06M |
| Advicenne | 23.86M |
| genOway Société anonyme | 22.50M |
| GenSight Biologics | 19.13M |
| Aelis Farma | 13.92M |
| Poxel | 11.26M |
| Aton | 8.45M |
| Oncodesign Precision Medicine Société anonyme | 6.13M |